Reigniting the Flame for Redifferentiation Strategies in Differentiated Thyroid Cancers: Journey of Tyrosine Kinase Inhibitors to Renewed Radioactive-Iodine Avidity. [PDF]
Endocrinol Metab (Seoul)Oh JM, Zhu L, Ahn BC.
europepmc +1 more source
Alternate-day Capecitabine Plus Trastuzumab for Frail HER2-positive Gastric Cancer: A Pilot Case Series. [PDF]
In VivoOdaira N, Sasaki M, Kanda J, Muneoka K.
europepmc +1 more source
Cooperation between GDNF/Ret and EphrinA/EphA4 signals for motor axon pathway selection in the limb [PDF]
, 2007 Knott, Laura, Knott, L. F., Knott, L.
core
Phosphoproteome-Entailed Kinase-Substrate Landscape of Human-DENV-2 Interaction. [PDF]
Int J Mol SciJabbar AA +11 more
europepmc +1 more source
[Trastuzumab Deruxtecan for EGFR-mutant Lung Adenocarcinoma with Acquired High-level HER2 Amplification: A Case Report]. [PDF]
Zhongguo Fei Ai Za ZhiGe X, Chen H, Cui S.
europepmc +1 more source
Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line. [PDF]
Sci RepStickler S +7 more
europepmc +1 more source
Invasive ductal and lobular carcinoma and receptor status in the genetic context of breast cancer. [PDF]
Sci RepAl-Masri M, Alayyan O, Safi Y.
europepmc +1 more source
Diagnostic and Therapeutic Challenges Related to HER2 Heterogeneity in Gastric Cancer: Bridging Molecular Pathology and Clinical Decision-Making. [PDF]
Int J Mol SciRosanu NM +6 more
europepmc +1 more source
Hsp90: A means to an end. [PDF]
Cell Stress ChaperonesWhalen KM, Freeman BC.
europepmc +1 more source
Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer. [PDF]
Breast Cancer Res TreatYamaguchi Y +18 more
europepmc +1 more source